Perinatal Asphyxia Clinical Trial
Official title:
Hypoxic-Ischemic Encephalopathy Therapy Optimization for Better Neuroprotection With Inhalative CO2 in Asphyxiated, Cooled, Mechanically Ventilated Neonates at Risk for Hypocapnia
This is a Phase I, open-label, single center trial to evaluate the feasibility and safety of low concentration CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with The hypothesis is that hypocapnia, which is driven by hyperventilation in the presence of metabolic acidosis, is deleterious to the injured brain and can be safely avoided with low concentration CO2 inhalation.
Specific aims: 1. To test the feasibility of low concentration inhalative CO2 gas mixture (5% CO2 + 95% air) administration to achieve a desired range of pCO2 of 40-60 mmHg in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe hypoxic-ischemic encephalopathy. 2. To test the safety of CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe hypoxic-ischemic encephalopathy. Term infants (≥ 36 weeks of gestation) will have to be at risk of hypocapnia to be eligible, as defined by a temperature corrected pCO2 ≤ 40 mmHg in blood gas analysis, at any time within six hours of life. The gas mixture will be administered through patient circuits in conventional ventilators. Administered CO2 level will be closely monitored at the inhalation circuit (constant 5% = 36 mmHg). Blood gas samples will be taken hourly to ensure targeted and tolerable pCO2 levels. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06322732 -
Optimization of Routine Obstetric and Neonatal Care in the Management of Severe Perinatal Asphyxia in Term or Near-term Newborns: Analysis of Sub-optimal Care
|
||
Completed |
NCT05687708 -
Effect of Non-nutritive Sucking on Transition to Oral Feeding in Infants With Asphyxia
|
N/A | |
Completed |
NCT00062452 -
Esophageal Motility and Airway Defenses Among Infants
|
N/A | |
Completed |
NCT05946681 -
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
|
||
Terminated |
NCT01626924 -
A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia
|
Phase 2 | |
Completed |
NCT02002039 -
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
|
Phase 2/Phase 3 | |
Completed |
NCT04820504 -
Augmented Infant Resuscitator to Enhance Newborn Ventilation
|
N/A | |
Completed |
NCT02071160 -
Melatonin for Neuroprotection Following Perinatal Asphyxia
|
Phase 1/Phase 2 | |
Recruiting |
NCT06090968 -
Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation
|
N/A | |
Completed |
NCT03854435 -
Determination of Heart Rate in Infants Needing Resuscitation at Birth
|
N/A | |
Active, not recruiting |
NCT05349175 -
Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement
|
N/A | |
Completed |
NCT03968861 -
Outcome After 24 Months of Participants in the TOBY Xenon Study
|
||
Recruiting |
NCT05574855 -
Evaluation of Haemodynamic in Neonates Treated With Hypothermia"
|
||
Completed |
NCT00624871 -
Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy
|
N/A |